Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Genpact LTDG · Entity 3760 | Director | November 12, 2025 | November 13, 2025 |
| Kenvue Inc.KVUE · Entity 3098 | Director | May 23, 2024 | May 28, 2024 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Genpact LTD
Report date November 12, 2025 · Filed November 13, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common SharesSEC Table I · non-derivative | Direct | 22,236 |
Reported balance
After 2025-11-12 transaction · row 1
1 source rowRow 1 · 2025-11-12 · Sale · Disposed 2,750 · Balance 22,236 |
Kenvue Inc.
Report date May 23, 2024 · Filed May 28, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Deferred Share UnitsSEC Table II · derivative / convertible security | Direct | 17,188.543 |
Reported balance
After 2024-05-23 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2024-05-23 · Grant · Acquired 9,259 · Balance 17,188.543 F1: Grant of Deferred Share Units ("DSUs") acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in shares of the Issuer's common stock upon termination of the Reporting Person's directorship (with each DSU representing the right to receive one share of Common Stock on the settlement date). F2: Includes DSUs acquired as dividend equivalents. |
Filing footnotes · ownership attribution and instrument terms
F1: Grant of Deferred Share Units ("DSUs") acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in shares of the Issuer's common stock upon termination of the Reporting Person's directorship (with each DSU representing the right to receive one share of Common Stock on the settlement date).
F2: Includes DSUs acquired as dividend equivalents.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 12, 2025 Filed Nov 13, 2025 16:53 UTC | Genpact LTD G · Entity 3760 | SaleCommon Shares | 2,750 | $45.65 | $125,537.50 |
DisclosureSEC source: 0001855053-25-000004 · wk-form4_1763070834.xml · nonDerivative · entry 1 Franklin Tamara · CIK 0001855053 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,236 Read SEC document |
| May 22, 2025 Filed May 27, 2025 17:00 UTC | Genpact LTD G · Entity 3760 | GrantCommon Shares | 4,825 | $0.00 | $0.00 |
DisclosureSEC source: 0001398659-25-000077 · wk-form4_1748379648.xml · nonDerivative · entry 1 Franklin Tamara · CIK 0001855053 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,986 F1 · shares: Represents an award of unvested restricted share units (RSUs) granted under the Genpact Limited 2017 Omnibus Incentive Compensation Plan. Each RSU entitles the holder to receive one common share at a future date. Subject to the reporting person's continued service, the RSUs will fully vest on December 31, 2025 and will be settled in common shares on December 31, 2026. Read SEC document |
| May 23, 2024 Filed May 28, 2024 21:26 UTC | Kenvue Inc. KVUE · Entity 3098 | GrantDeferred Share Units · Derivative | 9,259 | $19.44 | $179,994.96 |
DisclosureSEC source: 0001944048-24-000118 · wk-form4_1716931604.xml · derivative · entry 1 Franklin Tamara · CIK 0001855053 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,188.543 Underlying: Common Stock · 9,259 shares Expires not disclosed F1 · derivative.exercise_price: Grant of Deferred Share Units ("DSUs") acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in shares of the Issuer's common stock upon termination of the Reporting Person's directorship (with each DSU representing the right to receive one share of Common Stock on the settlement date). F1 · derivative.exercise_date: Grant of Deferred Share Units ("DSUs") acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in shares of the Issuer's common stock upon termination of the Reporting Person's directorship (with each DSU representing the right to receive one share of Common Stock on the settlement date). F1 · derivative.expiration_date: Grant of Deferred Share Units ("DSUs") acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in shares of the Issuer's common stock upon termination of the Reporting Person's directorship (with each DSU representing the right to receive one share of Common Stock on the settlement date). F2 · balance_after: Includes DSUs acquired as dividend equivalents. Read SEC document |
| May 02, 2024 Filed May 6, 2024 16:25 UTC | Genpact LTD G · Entity 3760 | GrantCommon Shares | 6,707 | $0.00 | $0.00 |
DisclosureSEC source: 0001398659-24-000074 · wk-form4_1715027098.xml · nonDerivative · entry 1 Franklin Tamara · CIK 0001855053 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,161 F1 · shares: Represents an award of unvested restricted share units (RSUs) granted under the Genpact Limited 2017 Omnibus Incentive Compensation Plan. Each RSU entitles the holder to receive one common share at a future date. Subject to the reporting person's continued service, the RSUs will fully vest on December 31, 2024 and will be settled in common shares on December 31, 2025. Read SEC document |
| August 23, 2023 Filed Aug 25, 2023 21:46 UTC | Kenvue Inc. KVUE · Entity 3098 | GrantDeferred Share Units · Derivative | 7,620 | $0.00 | $0.00 |
DisclosureSEC source: 0001944048-23-000028 · wk-form4_1692999948.xml · derivative · entry 1 Franklin Tamara · CIK 0001855053 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,620 Underlying: Common Stock · 7,620 shares Expires not disclosed F1 · derivative.exercise_price: Grant of Deferred Share Units acquired under the Issuer's Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). F1 · derivative.exercise_date: Grant of Deferred Share Units acquired under the Issuer's Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). F1 · derivative.expiration_date: Grant of Deferred Share Units acquired under the Issuer's Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). Read SEC document |
| May 04, 2023 Filed May 8, 2023 16:12 UTC | Genpact LTD G · Entity 3760 | GrantCommon Shares | 4,916 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-23-023496 · form4.xml · nonDerivative · entry 1 Franklin Tamara · CIK 0001855053 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,454 F1 · shares: Represents an award of unvested restricted share units (RSUs) granted under the Genpact Limited 2017 Omnibus Incentive Compensation Plan. Each RSU entitles the holder to receive one common share at a future date. Subject to the reporting person's continued service, the RSUs will fully vest on December 31, 2023 and will be settled in common shares on December 31, 2024. Read SEC document |
| May 19, 2022 Filed May 23, 2022 16:16 UTC | Genpact LTD G · Entity 3760 | GrantCommon Shares | 4,829 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-22-011510 · doc1.xml · nonDerivative · entry 1 Franklin Tamara · CIK 0001855053 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,538 F1 · shares: Represents an award of unvested restricted share units (RSUs) granted under the Genpact Limited 2017 Omnibus Incentive Compensation Plan. Each RSU entitles the holder to receive one common share at a future date. Subject to the reporting person's continued service, the RSUs will fully vest on December 31, 2022 and will be settled in common shares on December 31, 2023. Read SEC document |
| May 05, 2021 Filed May 7, 2021 16:08 UTC | Genpact LTD G · Entity 3760 | GrantCommon Shares | 3,709 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-21-009303 · doc1.xml · nonDerivative · entry 1 Franklin Tamara · CIK 0001855053 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,709 F1 · shares: Represents an award of unvested restricted share units (RSUs) granted under the Genpact Limited 2017 Omnibus Incentive Compensation Plan. Each RSU entitles the holder to receive one common share at a future date. Subject to the reporting person's continued service, the RSUs will fully vest on December 31, 2021 and will be settled in common shares on December 31, 2022. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.